NCT01264133View on ClinicalTrials.gov

A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

PHASE4TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

June 30, 2013

Study Completion Date

December 31, 2014

Conditions
Chronic Hepatitis B
Interventions
DRUG

Clevudine, Adefovir

Clevudine 30mg qd or Clevudine 30mg + Adefovir 10mg qd

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT01264133 - A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B | Biotech Hunter | Biotech Hunter